Methylone

2 trials

Filter these 2 trials by condition, phase, country and more.

Open in Search →

2 Registered trials

0 Recruiting

2 Completed trials

1 Sponsors

1 Countries

Phase II

Phase I/II

Phase II: 1 Phase I/II: 1

Indications tested

Post-traumatic stress disorder 2

Sponsors using this IMP

Transcend Therapeutics Inc. 2

All trials

2 total

IMPACT-EXT (Investigation of Methylone for Post-Traumatic Stress Disorder [PTSD]) Ended

2023-508381-16-00 Phase II 1 country Transcend Therapeutics Inc.
A Study to Assess the Use of Methylone in the Treatment of Post-Traumatic Stress Disorder (PTSD) Ended

2023-505874-14-00 Phase I/II 1 country Transcend Therapeutics Inc.

Showing 1–2 of 2 trials

← All drugs A–Z